162 related articles for article (PubMed ID: 1594550)
21. The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin.
Hewson G; Leighton GE; Hill RG; Hughes J
Br J Pharmacol; 1988 Jan; 93(1):79-84. PubMed ID: 3349234
[TBL] [Abstract][Full Text] [Related]
22. L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.
Soar J; Hewson G; Leighton GE; Hill RG; Hughes J
Pharmacol Biochem Behav; 1989 Jul; 33(3):637-40. PubMed ID: 2587606
[TBL] [Abstract][Full Text] [Related]
23. The effect of prostacyclin analogue--iloprost on the pancreas regeneration after caerulein-induced acute pancreatitis in rats.
Jurkowska G; Dlugosz JW; Rydzewska G; Andrzejewska A
J Physiol Pharmacol; 1996 Dec; 47(4):629-40. PubMed ID: 9116330
[TBL] [Abstract][Full Text] [Related]
24. Effects of peptide YY on CCK/CCK antagonist interactions in cerulein-induced pancreatic injury.
Tito JM; Rudnicki M; Robinson DC; Guiney WB; Adrian TE; Gold MS
Ann N Y Acad Sci; 1995 May; 757():410-2. PubMed ID: 7541974
[No Abstract] [Full Text] [Related]
25. The novel CCK antagonist L364,718 abolished caerulein- but potentiates morphine-induced antinociception.
Rattray M; Jordan CC; De Belleroche J
Eur J Pharmacol; 1988 Jul; 152(1-2):163-6. PubMed ID: 3208830
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic and protective effect of subcutaneous injections of L-364,718 on caerulein-induced acute pancreatitis.
Garcia-Montero AC; Manso MA; Rodriguez AI; De Dios I
Pancreas; 1994 May; 9(3):309-15. PubMed ID: 7517544
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
[TBL] [Abstract][Full Text] [Related]
28. Failure of a potent cholecystokinin antagonist to protect against diet-induced pancreatitis in mice.
Ohshio G; Saluja A; Leli U; Sengupta A; Steer ML
Pancreas; 1989; 4(6):739-43. PubMed ID: 2813332
[TBL] [Abstract][Full Text] [Related]
29. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
[TBL] [Abstract][Full Text] [Related]
30. Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models.
Tani S; Okabayashi Y; Nakamura T; Fujii M; Itoh H; Otsuki M
Pancreas; 1990 May; 5(3):284-90. PubMed ID: 2343042
[TBL] [Abstract][Full Text] [Related]
31. Effects of the specific cholecystokinin antagonist L 364,718 in experimental acute pancreatitis in the rat.
Sjövall S; Ahrén B; Stenram U
Eur Surg Res; 1988; 20(5-6):325-9. PubMed ID: 2465158
[TBL] [Abstract][Full Text] [Related]
32. Cholecystokinin-1 receptor protein up-regulation during pancreatic regeneration after acute haemorrhagic pancreatitis in rats.
Yoshikawa H; Nakamura H; Tashiro M; Yamaguchi T; Taguchi M; Fukumitsu K; Otsuki M
Eur J Clin Invest; 2004 Jul; 34(7):498-507. PubMed ID: 15255787
[TBL] [Abstract][Full Text] [Related]
33. Cerulein-induced pancreatitis in the ex vivo isolated perfused canine pancreas.
Clemens JA; Olson J; Cameron JL
Surgery; 1991 Apr; 109(4):515-22. PubMed ID: 2008656
[TBL] [Abstract][Full Text] [Related]
34. Peptide YY ameliorates cerulein-induced pancreatic injury in the rat.
Tito JM; Rudnicki M; Jones DH; Alpern HD; Gold MS
Am J Surg; 1993 Jun; 165(6):690-6. PubMed ID: 7685154
[TBL] [Abstract][Full Text] [Related]
35. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.
Green T; Dimaline R; Peikin S; Dockray GJ
Am J Physiol; 1988 Nov; 255(5 Pt 1):G685-9. PubMed ID: 3056036
[TBL] [Abstract][Full Text] [Related]
36. Effects of short-term administration of the CCK receptor antagonist, KSG-504, on regeneration of pancreatic acinar cells in acute pancreatitis in rats.
Okumura Y; Inoue H; Fujiyama Y; Bamba T
J Gastroenterol; 1995 Aug; 30(4):493-9. PubMed ID: 7550860
[TBL] [Abstract][Full Text] [Related]
37. Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis.
Toriumi Y; Samuel I; Wilcockson DP; Turkelson CM; Solomon TE; Joehl RJ
J Lab Clin Med; 1993 Oct; 122(4):450-4. PubMed ID: 8228560
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini.
Akiyama T; Tachibana I; Otsuki M
Int J Pancreatol; 1993 Oct; 14(2):167-73. PubMed ID: 7506744
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic fluid hypersecretion in rats after acute pancreatitis.
Czakó L; Yamamoto M; Otsuki M
Dig Dis Sci; 1997 Feb; 42(2):265-72. PubMed ID: 9052504
[TBL] [Abstract][Full Text] [Related]
40. Cholecystokinin augmentation of 'surgical' pancreatitis. Benefits of receptor blockade.
Modlin IM; Bilchik AJ; Zucker KA; Adrian TE; Sussman J; Graham SM
Arch Surg; 1989 May; 124(5):574-8. PubMed ID: 2469410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
